Immunogenicity and safety of 1 versus 2 doses of quadrivalent-inactivated influenza vaccine in children aged 3–8 years with or without previous influenza vaccination histories
This study assessed the immunogenicity and safety of a quadrivalent influenza split-virion vaccine (IIV4) in children with and without prior influenza vaccination. An open-label, phase IV clinical trial was conducted in healthy children aged 3–8 years in Pizhou, Jiangsu Province, China. Children wit...
Saved in:
| Main Authors: | Feng Wen, Sheng Liu, Li Zhou, Yinbiao Zhu, Wenjuan Wang, Mingwei Wei, Xinglong Xu, Yan Liu, Qi Shuai, Jun Yu, Pengfei Jing, Jingxin Li, Fengcai Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2468074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024-12-01) -
Assessment of Reactogenicity and Immunogenicity of the Quadrivalent Live Attenuated Influenza Vaccine
by: D. A. Lioznov, et al.
Published: (2018-06-01) -
The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases
by: Wanqin Tang, et al.
Published: (2025-08-01) -
Correction: The immunogenicity and safety of an inactivated quadrivalent influenza vaccine and a 23-valent pneumococcal polysaccharide vaccine in individuals with chronic diseases
by: Frontiers Production Office
Published: (2025-08-01) -
Evaluation of determinants of the serological response to the quadrivalent split‐inactivated influenza vaccine
by: Shaohuan Wu, et al.
Published: (2022-05-01)